455 related articles for article (PubMed ID: 17111838)
1. [The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats].
Liu XL; Tang J; Song J; He J; Xu P; Peng WX
Yao Xue Xue Bao; 2006 Sep; 41(9):882-7. PubMed ID: 17111838
[TBL] [Abstract][Full Text] [Related]
2. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
[TBL] [Abstract][Full Text] [Related]
3. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.
Song KH; Fasano A; Eddington ND
Int J Pharm; 2008 Mar; 351(1-2):8-14. PubMed ID: 17954018
[TBL] [Abstract][Full Text] [Related]
4. Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data.
Hsiao P; Sasongko L; Link JM; Mankoff DA; Muzi M; Collier AC; Unadkat JD
J Pharmacol Exp Ther; 2006 May; 317(2):704-10. PubMed ID: 16415090
[TBL] [Abstract][Full Text] [Related]
5. Single-dose and steady state pharmacokinetics of CSA and two main primary metabolites, AM1 and AM4n in patients with rheumatic/autoimmune diseases.
Suchy D; Dostalek M; Perinova I; Brozmanova H; Grundmann M; Vyskocil V; Mayer O
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):269-74. PubMed ID: 22286813
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study on pharmacokinetics of tetramethylpyrazine, ferulic acid and their compatibility].
Feng B; Zhang J; Zhang J; Chen G; Xu X
Zhongguo Zhong Yao Za Zhi; 2010 Apr; 35(7):900-3. PubMed ID: 20575396
[TBL] [Abstract][Full Text] [Related]
7. Enhanced bioavailability of verapamil after oral administration with hesperidin in rats.
Piao YJ; Choi JS
Arch Pharm Res; 2008 Apr; 31(4):518-22. PubMed ID: 18449511
[TBL] [Abstract][Full Text] [Related]
8. Improvement of cyclosporine A bioavailability by incorporating ethyl docosahexaenoate in the microemulsion as an oil excipient.
Hirunpanich V; Sato H
Eur J Pharm Biopharm; 2009 Oct; 73(2):247-52. PubMed ID: 19560537
[TBL] [Abstract][Full Text] [Related]
9. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
Zuo Z; Tam YK; Diakur J; Wiebe LI
J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
[TBL] [Abstract][Full Text] [Related]
10. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
Lehle K; Kirchner GI; Rupprecht L; Gruber M; Birnbaum DE; Schmid FX; Preuner JG
Transplant Proc; 2007 Dec; 39(10):3323-8. PubMed ID: 18089380
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a new pulmonary cyclosporine a powder formulation for prevention of transplant rejection in rats.
Zijlstra GS; Wolting J; Prop J; Petersen AH; Hinrichs WL; Uges DR; Kerstjens HA; van der Bij W; Frijlink HW
J Heart Lung Transplant; 2009 May; 28(5):486-92. PubMed ID: 19416778
[TBL] [Abstract][Full Text] [Related]
12. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
[TBL] [Abstract][Full Text] [Related]
13. Concurrent administration of water-soluble vitamin E can increase the oral bioavailability of cyclosporine a in healthy dogs.
Fischer JR; Harkin KR; Freeman LC
Vet Ther; 2002; 3(4):465-73. PubMed ID: 12584684
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
15. Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp.
Qiu W; Jiang XH; Liu CX; Ju Y; Jin JX
Phytother Res; 2009 Nov; 23(11):1553-8. PubMed ID: 19370549
[TBL] [Abstract][Full Text] [Related]
16. Brain pharmacokinetics of tetramethylpyrazine after intranasal and intravenous administration in awake rats.
Feng J; Li F; Zhao Y; Feng Y; Abe Y
Int J Pharm; 2009 Jun; 375(1-2):55-60. PubMed ID: 19481691
[TBL] [Abstract][Full Text] [Related]
17. Angiotension converting enzyme inhibition and calcium channel blockage improves cyclosporine induced glucose intolerance in rats.
Yavuz DG; Tuğlular S; Koçak H; Atakan A; Ozener C; Akoğlu E; Akalin S
Transplant Proc; 2004; 36(1):171-4. PubMed ID: 15013337
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients.
Dotti G; Gaspari F; Caruso R; Perico N; Remuzzi G; Barbui T; Rambaldi A
Haematologica; 2001 Mar; 86(3):311-5. PubMed ID: 11255279
[TBL] [Abstract][Full Text] [Related]
19. Time-course effects of St John's wort on the pharmacokinetics of cyclosporine in dogs: interactions between herbal extracts and drugs.
Fukunaga K; Orito K
J Vet Pharmacol Ther; 2012 Oct; 35(5):446-51. PubMed ID: 22091645
[TBL] [Abstract][Full Text] [Related]
20. Effects of tauroursodeoxycholate solutions on cyclosporin A bioavailability in rats.
Balandraud-Pieri N; Queneau PE; Caroli-Bosc FX; Bertault-Pérès P; Montet AM; Durand A; Montet JC
Drug Metab Dispos; 1997 Aug; 25(8):912-6. PubMed ID: 9280397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
